SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-015842
Filing Date
2020-08-14
Accepted
2020-08-14 16:11:45
Documents
64
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1536262
2 ex3-2.htm EX-3.2 1159
3 ex3-2_001.jpg GRAPHIC 116078
4 ex3-3.htm EX-3.3 1968
5 ex3-3_001.jpg GRAPHIC 217484
6 ex3-3_002.jpg GRAPHIC 153741
7 ex31-1.htm EX-31.1 18526
8 ex31-2.htm EX-31.2 18818
9 ex32-1.htm EX-32.1 10445
  Complete submission text file 0001493152-20-015842.txt   6300611

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE aker-20200630.xml EX-101.INS 802875
11 XBRL SCHEMA FILE aker-20200630.xsd EX-101.SCH 86694
12 XBRL CALCULATION FILE aker-20200630_cal.xml EX-101.CAL 58040
13 XBRL DEFINITION FILE aker-20200630_def.xml EX-101.DEF 218699
14 XBRL LABEL FILE aker-20200630_lab.xml EX-101.LAB 522396
15 XBRL PRESENTATION FILE aker-20200630_pre.xml EX-101.PRE 308740
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 201105179
SIC: 2835 In Vitro & In Vivo Diagnostic Substances